Author

Mária Papp 1

1 University of Debrecen, MHSC Institute of Medicine

A Multicenter, International Cohort Analysis of 1435 Patients to Support Clinical Trial Design in Acute Pancreatitis

Balint Eross, Nelli Farkas, Lilla Hanák, Judit Bajor, Patrícia Sarlós, József Czimmer, Aron Vincze, Szilárd Gódi, Tamás Takács, László Czakó, Balazs Nemeth, Dóra Illés, Balázs Kui, Erika Darvasi, Ferenc Izbéki, Adrienn Halász, Veronika Dunas, László Gajdán, József Hamvas, Mária Papp, Ildikó Földi, Krisztina Eszter Fehé

Ascites

Mária Papp

BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY BASED ON INTERIM RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Klaudia Farkas, Barbara Dorottya Lovasz, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Tünde Kristóf, Peter L Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze;;

Cirrhosis

Mária Papp

EARLY ACHIEVABLE SEVERITY (EASY) INDEX FOR SIMPLE AND ACCURATE EXPEDITE RISK STRATIFICATION IN ACUTE PANCREATITIS

Balázs Kui, Szilárd Gódi, Judit Bajor, Imola Torok, Melania Macaria, Hunor Farkas, Artautas Mickevicius, Ville Sallinen, Elena Ramirez Maldonado, Mária Papp, György Kovács, Patrícia Sarlós, Shamil Galeev, Balazs Nemeth, Aron Vincze, Petr Pencik, Imanta Ozola Zalite, Aldis Pukitis, Andrey Litvin, Inna Kovalskaya, József

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, Petra Anna Golovics, Barbara Dorottya Lovasz, Lorant Gonczi, János Banai, László Bene, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamá

FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PREDICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Petra Anna Golovics, Barbara Dorottya Lovasz, Zsuzsanna Kürti, Mariann Rutka, Zsuzsanna Vegh, Krisztina Barbara Gecse, Klaudia Farkas, János Banai, László Bene, Lorant Gonczi, Beata Gasztonyi, Tünde Kristóf, László Lakatos, Pal Miheller, Karoly Palatka, Árpád V. Patai, Mária Papp, Ágnes Szabone Salamon, Tamás Szamosi, Zo

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY

Tamás Molnár, Mariann Rutka, Ferenc Nagy, Péter Fritz, László Lakatos, Pal Miheller, Zsuzsanna Erdelyi, Tamás Szamosi, Eszter Schäfer, Aron Vincze, Patrícia Sarlós, János Banai, Ágota Kovács, János Novák, Ágnes Szabone Salamon, Attila Szepes, Nora Szigeti, Mark Juhasz, Katalin Müllner, Zsolt Barta, Orsolya Kadenczki, A

Item 1 - 10 / 42
1
2 3 4 5